Clark Chen, MD
Affiliations: | 2017- | Neurosurgery | University of Minnesota, Twin Cities, Minneapolis, MN |
Google:
"Clark Chen"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Prager BC, Vasudevan HN, Dixit D, et al. (2020) The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies. Cancer Discovery |
| Cloughesy T, Petrecca K, Walbert T, et al. (2019) LTBK-08. TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA Neuro-Oncology. 21: vi284-vi284 |
| Ferreira C, Alaei P, Chen C, et al. (2019) RTHP-32. FIRST EXPERIENCE WITH GAMMATILE PERMANENT IMPLANTS FOR RECURRENT BRAIN TUMORS Neuro-Oncology. 21: vi216-vi216 |
| Koga T, Chaim I, Markmiller S, et al. (2019) TMOD-28. AUTHENTIC HUMAN GLIOMA MODELING USING GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS Neuro-Oncology. 21: vi268-vi269 |
| Aiken R, Chen C, Cloughesy T, et al. (2019) ATIM-33. INTERIM RESULTS OF A PHASE II MULTI-CENTER STUDY OF ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192) Neuro-Oncology. 21: vi8-vi9 |
| Mulford KL, Chen C, Dusenbery K, et al. (2019) Tumor Cavity Shape Characteristics Do Not Predict Local Control in Patients with Resected Brain Metastases Receiving Adjuvant SRS International Journal of Radiation Oncology Biology Physics. 103 |
| Joshi R, Alattar A, Carroll K, et al. (2018) Path-03. Prognostic Importance Of Tumor Grade In The Post-Genomic Era Neuro-Oncology. 20 |
| Cloughesy TF, Ostertag D, Landolfi JC, et al. (2017) Durable complete responses observed in IDH1 mutated high grade glioma at first recurrence undergoing treatment with Toca 511 and Toca FC. Journal of Clinical Oncology. 35: e13504-e13504 |
| Joshi R, Hirshman B, Ali MA, et al. (2017) CMET-45. USING CUMULATIVE INTRACRANIAL TUMOR VOLUME AS A PROGNOSTIC FACTOR IN THE GI-SPECIFIC GRADED PROGNOSTIC ASSESSMENT (GPA) MODEL Neuro-Oncology. 19: vi48-vi49 |
| Cloughesy T, Landolfi J, Vogelbaum M, et al. (2017) ATIM-02. DURABLE RESPONSES OBSERVED IN IDH1 WILDTYPE AND MUTANT RECURRENT HIGH GRADE GLIOMA (rHGG) WITH TOCA 511 & TOCA FC TREATMENT Neuro-Oncology. 19: vi26-vi26 |